Covid Vaccination Argentina

[gracielle]

Updated Oct. 27, 2021

COVID-19 Booster Shot

Learn who is eligible for a COVID-19 booster shot.

www.cdc.gov

29 October 2021
New CDC Study: Vaccination Offers Higher Protection than Previous COVID-19 Infection

CDC Newsroom

Press releases, advisories, telebriefings, transcripts and archives.

www.cdc.gov

 

[gracielle]

3 November 2021

Covid-19: la OMS aprobó el uso de emergencia de la vacuna Covaxin | La provincia de Buenos Aires espera la llegada de 15 millones de dosis desde la India

La Organización Mundial de la Salud (OMS) <b>aprobó este miércoles el uso de emergencia de la vacuna contra el coronavirus Covaxin, </b>del laboratorio indio Bharat Biotech. La provincia de Buenos Aires anunció en junio un acuerdo para adquirir 15 mill...

www.pagina12.com.ar

WHO approved on Wednesday the emergency use of the vaccine against the coronavirus Covaxin, from the Indian laboratory Bharat Biotech. Province of BA expects 15M doses to arrive from India. This vaccine, which has an efficacy of 78%, is recommended for all persons 18 years of age and older. It requires two doses four weeks apart and "is particularly suitable for resource-poor countries because it can be easily stored," the WHO statement said. It is the first vaccine developed and manufactured entirely in India to be approved by the UN organization....Once they arrive in the province, they will be offered to the national gov't so that "they can be distributed among all the provinces of Argentina", said Governor Axel Kicillof.

3 November 2021

Eficacia, inmunidad y seguridad: los detalles de Covaxin, la nueva vacuna aprobada por la OMS

La entidad sanitaria mundial aprobó el desarrollo de India que se suma a las otras siete ya autorizadas. En Argentina todavía no fue aprobada por la ANMAT

www.infobae.com

The details of Covaxin, the new vaccine approved by the WHO. In Argentina it has not yet been approved by ANMAT....

 

[Somewhereinba]

Updated Oct. 27, 2021

COVID-19 Booster Shot

Learn who is eligible for a COVID-19 booster shot.

www.cdc.gov

29 October 2021
New CDC Study: Vaccination Offers Higher Protection than Previous COVID-19 Infection

CDC Newsroom

Press releases, advisories, telebriefings, transcripts and archives.

www.cdc.gov

Not sure why anyone would trust a study from the CDC regarding vaccines. Does anyone really think they would come out and say that natural immunity offers better and longer protection than the vaccine as the Israel study proved? Sorry but they are extremely biased - their hand is literally in the jar they are feeding people.

 

[lunar]

Does anyone really think they would come out and say that natural immunity offers better and longer protection than the vaccine as the Israel study proved?

Was this revolutionary study conducted before or after Israel vaccinated the entire population?

Every self-respecting conspiracy theorist knows that all people are naturally immune to the coronavirus, and this whole story about the pandemic was invented by CDC, NIH, FDA and other government organizations.

 

[gracielle]

27 Oct 2021

Merck will allow drugmakers in other countries to make its COVID-19 pill

The drug, known as molnupiravir, has shown promise in treating the disease. The agreement to license its production could help millions of people in the developing world gain access to it.

www.npr.org

From: Medicines and Healthcare products Regulatory Agency. Published 4 Nov 2021

First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA

The antiviral was found to be safe and effective following a stringent review of the available evidence.

www.gov.uk

 

[cuando_volverá]

Was this revolutionary study conducted before or after Israel vaccinated the entire population?

Every self-respecting conspiracy theorist knows that all people are naturally immune to the coronavirus, and this whole story about the pandemic was invented by CDC, NIH, FDA and other government organizations.

Not really sure what your point is. This conspiracy website suggests that the vaccine may not be very effective:

Israel, Once the Model for Beating Covid, Faces New Surge of Infections

One of the most vaccinated societies, Israel now has one of the highest infection rates in the world, raising questions about the vaccine’s efficacy.

www.nytimes.com

The article is from August.

 

[gracielle]

3 Nov 2021

China’s Covid-19 cases spike

China reported a record 93 Covid-19 infections in a single day on November 2, 2021, amid the latest outbreak fuelled by the Delta variant. It was the highest daily case figure in China since August…

www.scmp.com

 

[gracielle]

4 Nov 2021 by Pablo Sigal

Pastilla contra el Covid: el laboratorio trabaja con la ANMAT para que el antiviral llegue al país

Así lo aseguraron a Clarín fuentes de la industria. Y desde Nación dijeron que lo están evaluando. Tras la aprobación en el Reino Unido, Europa también se mostró optimista para su autorización.

www.clarin.com

Covid pill (Lagevrio/molnupiravir)....Clarin has learned from pharmaceutical industry sources, the local subsidiary of the Merck Sharpe & Dohme laboratory, which produces this new drug, is working with ANMAT and the Ministry of Health so that Argentina can have access to this pill in the shortest possible time. UK approved the drug for patients who have at least one risk factor (obesity, diabetes, hypertension and renal failure), although each regulatory agency can decide whether to restrict it to that population or extend it to those patients who do not have comorbidities. The clinical trial, which had 55% of volunteers in LatAm of which Argentina took part, showed a 50% reduction in the risk of hospitalization. In addition, in the group that took the pill, none died and in the group that received the placebo, there were 8 fatalities.

The EMA said in the last few hours that it is seeking to accelerate the study it launched last week on this drug, with a view to authorizing its marketing. "We will try to accelerate our assessment in order to obtain authorization in the shortest possible time," said Marco Cavaleri, head of the EMA's vaccination strategy. For now, there is no exact date for the antiviral to be given the green light in Europe. It is also expected that the US FDA will give its verdict shortly. These two instances would be key to speed up the authorization process in Argentina as well....

....Although it was reported on Thursday that Argentina could be the producer of a generic of this antiviral, Bugarin explained that "this possibility exists only for countries considered by the World Bank as low and medium resource countries, a list in which Argentina is not included"....Clarín also consulted sources from the Ministry of Health to find out what are the chances that Argentines will have access to this drug in the short term. The answer was cautious: "It is an antiviral that has been approved only in the UK for the time being. We are evaluating it. When we have information we will communicate it", they said.

 

[gracielle]

5 Nov 2021 by Fabiola Czubaj

Contra el anuncio oficial: el Gobierno aplicó Sinopharm a los chicos de 3 a 11 años antes que China, el país productor

Al comunicar el inicio de la vacunación en menores de 12, el 1° de octubre pasado, Vizzotti dijo que Pekín ya la usaba en niños y adolescentes; sin embargo, empezó a administrarla en esa franja etaria la semana pasada

www.lanacion.com.ar

Against the official announcement: the Gov't applied Sinopharm to children from 3 to 11 years of age before China, the producer country....There were 500 million "children and adolescents" who were being vaccinated with Sinopharm in China, according to the National Minister of Health, Carla Vizzotti, when the Gov't announced on October 1 that it would imitate the strategy for children between 3 and 11 years of age. Thus, with the decision to allocate a stock of 10M doses to children, a campaign which effectively started on October 12 in the subgroup with comorbidities, Argentina was almost one month ahead of China, the producer country.

However it was only last Friday that China's National Health Commission announced that it had began to apply the dose to children under 12 the previous day due to the increase in the number of infections, having approved the use in June. Argentina became the second country in the world to test this vaccine against Covid in this age group. It was last week that Bahrain's National Medical Commission to Combat Coronavirus reported approval for use of Sinopharm for that population. The UAE was the first country to license Sinopharm between the ages of 3 and 11 with as yet unpublished data from a Phase III study of 900 boys, ages 3 to 17, with no comorbidities.

 

[gracielle]

5 Nov 2021 by Alex Knapp

Pfizer Says Its Covid Pill Reduced Risk Of Hospitalization And Death By 89% In Clinical Study

The pharmaceutical giant will submit the data to the FDA to continue its application for emergency use authorization.

www.forbes.com